Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 EUR | +4.27% | +3.83% | +9.42% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Business Summary
Number of employees: 1
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -72.59% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -72.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Sören Rose
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,137,498 | 2,099,049 ( 40.86 %) | 0 | 40.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 2.68M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- T5O Stock
- Company bioXXmed AG